 |
 |
Departments: MRC Social, Genetic and Developmental Psychiatry Centre and Biostatistics Starting: September 2013 Deadline for applications: Friday 22 March 2013, 09:00 (GMT) A 4-year PhD studentship is available in Bioinformatics/Biostatistics, funded by Janssen Pharmaceuticals (a company of Johnson & Johnson), to develop methods to identify novel biomarkers for disease progression in Alzheimer’s disease. This PhD research will develop and assess approaches for building biomarker prediction models that have clinical utility. This presents an exciting opportunity to develop cutting edge tools for the analysis of clinical and omics data that will be applied to on-going studies. The student will have incredible opportunities to exploit data from patient records and large EU funded projects such as the European Medical Informatics Framework. The project will be jointly supervised by Dr Richard Dobson and Dr Mizan Khondoker (KCL) in collaboration with Professor Simon Lovestone and colleagues at Janssen Pharmaceuticals (Johnson & Johnson). The student will be part of the Bioinformatics and Biostatistics group at the Institute of Psychiatry, KCL, a thriving research group with over twenty researchers, and may have the opportunity to spend time at Johnson & Johnson during the studentship. Funding notes: The studentship includes home fees and a full maintenance stipend of approximately £16,500 per annum. Applicants should be UK/EU nationals and resident in the UK for three years prior to starting the PhD. Non-EU candidates can apply but would have to cover additional fees. How to apply: To apply, you must register and complete the application form online using the King’s College London application system - follow the instructions at http://www.kcl.ac.uk/iop/research/pgr/phdstudentships/Janssen.aspx We are unable to accept any applications by email or sent directly to the Institute. You may leave the list at any time by sending the command SIGNOFF allstat to [log in to unmask], leaving the subject line blank.